Journal of Health Sciences & Surveillance System

Current Issue

By Issue

By Author

By Subject

Author Index

Keyword Index

About Journal

Aims and Scope

Editorial Board

Publication Ethics

Indexing and Abstracting

Related Links

FAQ

Peer Review Process

News

Investigating the Prevalence of Thyroid Disorders and Their Contributing Factors in Iran: A Cross-Sectional Analysis

Document Type : Original Article

Authors

1 Endocrinology and Metabolism Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran

2 Non-Communicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran

3 Department of Public Health, Ferdows Faculty of Medical Sciences, Birjand University of Medical Sciences, Birjand, Iran

4 Department of Public Health, Qaen Faculty of Medical Sciences, Birjand University of Medical Sciences, Birjand, Iran

5 Department of Dermatology, Shiraz University of Medical Sciences, Shiraz, Iran

6 Department of Persian Medicine, Fasa University of Medical Sciences, Fasa, Iran

7 The Persian Gulf Tropical Medicine Research Center, The Persian Gulf Biomedical Sciences Research Institute, Bushehr University of Medical Sciences, Bushehr, Iran

8 Department of Biostatistics and Epidemiology, Faculty of Health and Nutrition, Bushehr University of Medical Sciences, Bushehr, Iran

Abstract

Background: Thyroid problems have been reported in over 110 countries worldwide. In some countries, the prevalence of known thyroid disorders has been reported to be as high as 18.9%. Given that thyroid dysfunction can adversely affect adult health, we aimed to assess the prevalence of thyroid disease and related factors in the Fasa Persian Cohort Study Centre.
Methods: This cross-sectional study was conducted in southwestern Iran. It included 10,132 participants, with an average age of 48.63. Demographic and clinical data were used as baseline cohort information. Multiple logistic regression analysis was conducted to investigate factors associated with thyroid disease.
Results: The prevalence of thyroid disease was 8.8%. According to the results of the multiple analysis gender (AORfemale/ male=5.94.95% CI: 1.66-7.58), education level (AOR Literate/ Illiterate=1.21, 95% CI: 1.04-1.40), diabetes (AORYes/No=1.32, 95% CI: 1.09-1.69), hypertension (AORYes/No=1.38, 95% CI: 1.17-1.64), depression (AORYes/No=1.72, 95% CI: 1.38-2.13) were associated with the odds of thyroid disease. Also, metabolic equivalent task (MET) (AOR=0.99, 95% CI: 0.02-0.083), duration sleep (AOR6- 7/≤5=0.77, 95% CI: 0.61-0.97), and duration sleep (AOR≥8/≤5=0.80, 95% CI: 0.64-0.99) were  identified as protective factors in the study.
Conclusion: This study’s findings indicated that the total prevalence of thyroid disease in adults was 8.8%. The researchers found that gender, education level, hypertension, diabetes, and depression increased the odds of thyroid disease. In addition, duration of sleep and MET were identified as protective factors. Further consideration of thyroid disease and screening for this population is recommended.

Highlights

Mehdi Sharafi (Google Scholar)

Sima Afrashteh (Google Scholar)

Keywords

References
  1. Al Shahrani AS, El-Metwally A, Al-Surimi K, Salih SB, Saleh Y, Al-Shehri A, et al. The epidemiology of thyroid diseases in the Arab world: A systematic review. Public Health Epidemiol. 2016;8(2):17-26. doi: 10.5897/JPHE2015.0713.
  2. Nageswari CS, Kumar MV, Raveena C, Sharma JS, Devi MY. An Identification and Classification of Thyroid Diseases Using Deep Learning Methodology. REVISTA GEINTEC-GESTAO INOVACAO E TECNOLOGIAS. 2021;11(2):2004-15.
  3. Ogbonna SU, Ezeani IU. Risk factors of thyroid dysfunction in patients with type 2 diabetes mellitus. Front Endocrinol. 2019;10:440. doi: 3389/fendo.2019.00440, PMCID: PMC6621929, PMID: 31333585
  4. Hosseini Ms, Amouzegar DA, tohidi Dm, Tahmasebinejad Z, azizi Df. Prevalence and Incidence of Thyroid Dysfunction in Individuals Aged Over 55 Years )Tehran Thyroid Study. IIJEM. 2016;18(3):165-72.
  5. Sarfo-Kantanka O, Kyei I, Sarfo FS, Ansah EO. Thyroid disorders in Central Ghana: the influence of 20 years of iodization. J. Thyroid Res. 2017;2017. doi: 1155/2017/7843972, PMCID: PMC5514328, PMID: 28744391.
  6. Aminorroaya A, Meamar R, Amini M, Feizi A, Tabatabae A, Faghih Imani E. Incidence of thyroid dysfunction in an Iranian adult population: the predictor role of thyroid autoantibodies: results from a prospective population-based cohort study. Eur J Med Res. 2017;22(1):1-10. doi: 1186/s40001-017-0260-2 , PMCID: PMC5480126, PMID: 28637498
  7. Franklyn JA. Thyroid disease and its treatment: short- and long-term consequences. J R Coll Physicians Lond. 1999;33(6):564-7. PMCID: PMC9665777 , PMID: 10633337.
  8. Diab N, Daya NR, Juraschek SP, Martin SS, McEvoy JW, Schultheiß UT, et al. Prevalence and risk factors of thyroid dysfunction in older adults in the community. Sci Rep. 2019;9(1):1-8. doi: 1038/s41598-019-49540-z, PMCID: PMC6739389, PMID: 31511587.
  9. Posadas-Romero C, Jorge-Galarza E, Posadas-Sanchez R, Acuna-Valerio J, Juárez-Rojas JG, Kimura-Hayama E, et al. Fatty liver largely explains associations of subclinical hypothyroidism with insulin resistance, metabolic syndrome, and subclinical coronary atherosclerosis. Eur J Endocrinol. 2014;171(3):319-25. doi: 10.1530/EJE-14-0150, PMID: 25053728.
  10. Da Costa ABB, Pellizzari C, Carvalho GA, Sant'Anna BC, Montenegro RL, Zammar Filho RG, et al. High prevalence of subclinical hypothyroidism and nodular thyroid disease in patients on hemodialysis. Hemodial Int. 2016;20(1):31-7. doi: 10.1111/hdi.12339, PMID: 26246426.
  11. Alam Khan V, Khan MA, Akhtar S. Thyroid disorders, etiology and prevalence. J Med Sci. 2002;2(2):89-94. doi: 10.3923/jms.2002.89.94.
  12. Legakis I, Manousaki M, Detsi S, Nikita D. Thyroid function and prevalence of anti-thyroperoxidase (TPO) and anti-thyroglobulin (Tg) antibodies in outpatients hospital setting in an area with sufficient iodine intake: influences of age and sex. Acta Med Iran. 2013:25-34. PMID: 23456581.
  13. Maniakas A, Davies L, Zafereo ME. Thyroid disease around the world. Otolaryngol Clin North Am. 2018;51(3):631-42. doi: 10.1016/j.otc.2018.01.014. PMID: 29548512.
  14. Garmendia Madariaga A, Santos Palacios S, Guillén-Grima F, Galofré JC. The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis. J Clin Endocrinol Metab. 2014;99(3):923-31. doi: 10.1210/jc.2013-2409. PMID: 24423323.
  15. Khattak RM, Ittermann T, Nauck M, Below H, Völzke H. Monitoring the prevalence of thyroid disorders in the adult population of Northeast Germany. Popul Health Metr. 2016;14(1):1-11. doi: 10.1186/s12963-016-0111-3, PMCID: PMC5101821, PMID: 27833458.
  16. Olmos RD, De Figueiredo R, Aquino E, Lotufo P, Bensenor I. Gender, race and socioeconomic influence on diagnosis and treatment of thyroid disorders in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Braz J Med Biol Res. 2015;48:751-8. doi: 10.1590/1414-431X20154445, PMCID: PMC4541696, PMID: 26108100.
  17. Kim YA, Park YJ. Prevalence and risk factors of subclinical thyroid disease. Endocrinol Metab. 2014;29(1):20-9. doi: 10.3803/EnM.2014.29.1.20, PMCID: PMC3970282, PMID: 24741450.
  18. Parad MT, Fararouei M, Mirahmadizadeh AR, Afrashteh S. Thyroid cancer and its associated factors: A population‐based case‐control study. Int J Cancer. 2021;149(3):514-21. doi: 10.1002/ijc.33537, PMID: 33634859.
  19. Farjam M, Bahrami H, Bahramali E, Jamshidi J, Askari A, Zakeri H, et al. A cohort study protocol to analyze the predisposing factors to common chronic non-communicable diseases in rural areas: Fasa Cohort Study. BMC public health. 2016;16(1):1-8. doi: 10.1186/s12889-016-3760-z, PMCID: PMC5069851, PMID: 27756262.
  20. Abu-Helalah M, Alshraideh HA, Al-Sarayreh SA, Al Shawabkeh AHK, Nesheiwat A, Younes N, et al. A cross-sectional study to assess the prevalence of adult thyroid dysfunction disorders in Jordan. Thyroid. 2019;29(8):1052-9. doi: 10.1089/thy.2018.0579, PMID: 31146635.
  21. Alqahtani SAM. Prevalence and Characteristics of Thyroid Abnormalities and Its Association with Anemia in ASIR Region of Saudi Arabia: A Cross-Sectional Study. Clin Pract. 2021;11(3):494-504. doi: 10.3390/clinpract11030065, PMCID: PMC8395449, PMID: 34449542.
  22. Popoveniuc G, Jonklaas J. Thyroid nodules. Med Clin North Am. 2012;96(2):329-49. doi: 10.1016/j.mcna.2012.02.002, PMCID: PMC3575959, PMID: 22443979.
  23. Valdes S, Maldonado-Araque C, Lago-Sampedro A, Lillo JA, Garcia-Fuentes E, Perez-Valero V, et al. Population-based national prevalence of thyroid dysfunction in Spain and associated factors: Di@ bet. es Study. Thyroid. 2017;27(2):156-66. doi: 10.1089/thy.2016.0353, PMID: 27835928.
  24. Markanday S, Brennan SL, Gould H, Pasco JA. Sex-differences in reasons for non-participation at recruitment: Geelong Osteoporosis Study. BMC Res Notes. 2013;6(1):1-7. doi: 10.1186/1756-0500-6-104, PMCID: PMC3606438, PMID: 23506528.
  25. Baral N, Lamsal M, Koner B, Koirala S. Thyroid dysfunction in eastern Nepal. Southeast Asian J Trop Med Public Health. 2002;33(3):638-41. PMID: 12693603.
  26. Ittermann T, Khattak RM, Nauck M, Cordova CM, Völzke H. Shift of the TSH reference range with improved iodine supply in Northeast Germany. Eur J Endocrinol. 2015;172(3):261-7. doi: 10.1530/EJE-14-0898, PMID: 25452467.
  27. Meisinger C, Ittermann T, Wallaschofski H, Heier M, Below H, Kramer A, et al. Geographic variations in the frequency of thyroid disorders and thyroid peroxidase antibodies in persons without former thyroid disease within Germany. Eur J Endocrinol. 2012;167(3):363-71. doi: 10.1530/EJE-12-0111,PMID: 22700599.
  28. Khatiwada S, Kc R, Sah SK, Khan SA, Chaudhari RK, Baral N, et al. Thyroid dysfunction and associated risk factors among Nepalese diabetes mellitus patients. Int J Endocrinol. 2015;2015. doi: 10.1155/2015/570198, PMCID: PMC4576006, PMID: 26435714.
  29. Demitrost L, Ranabir S. Thyroid dysfunction in type 2 diabetes mellitus: A retrospective study. Indian J Endocrinol Metab. 2012;16(Suppl 2):S334. doi: 10.4103/2230-8210.104080, PMCID: PMC3603066, PMID: 23565418.
  30. Al-Geffari M, Ahmad NA, Al-Sharqawi AH, Youssef AM, AlNaqeb D, Al-Rubeaan K. Risk factors for thyroid dysfunction among type 2 diabetic patients in a highly diabetes mellitus prevalent society. Int J Endocrinol. 2013;2013. doi: 10.1155/2013/417920, PMCID: PMC3884781, PMID: 24454365.
  31. Nishi M. Diabetes mellitus and thyroid diseases. Diabetol Int. 2018;9(2):108-12. doi: 10.1007/s13340-018-0352-4. PMCID: PMC6224947, PMID: 30603357.
  32. Berta E, Lengyel I, Halmi S, Zrínyi M, Erdei A, Harangi M, et al. Hypertension in thyroid disorders. Front Endocrinol. 2019;10:482. doi: 10.3389/fendo.2019.00482, PMCID: PMC6652798, PMID: 31379748.
  33. Cappola AR, Ladenson PW. Hypothyroidism and atherosclerosis. J Clin Endocrinol Metab. 2003;88(6):2438-44. doi: 10.1210/jc.2003-030398, PMID: 12788839.
  34. Prisant LM, Gujral JS, Mulloy AL. Hyperthyroidism: a secondary cause of isolated systolic hypertension. J Clin Hypertens. 2006;8(8):596-9. doi: 10.1111/j.1524-6175.2006.05180.x, PMCID: PMC8109671, PMID: 16896276.
  35. Carlson MD, Morrison RS. Study design, precision, and validity in observational studies. J Palliat Med. 2009;12(1):77-82. doi: 10.1089/jpm.2008.9690, PMCID: PMC2920077, PMID: 19284267.
  36. Kim W, Lee J, Ha J, Jo K, Lim D-J, Lee J-M, et al. Association between sleep duration and subclinical thyroid dysfunction based on nationally representative data. J Clin Med. 2019;8(11):2010. doi: 10.3390/jcm8112010, PMCID: PMC6912782, PMID: 31752113.
  37. Brabant G, Prank K, Ranft U, Schuermeyer T, Wagner T, Hauser H, et al. Physiological regulation of circadian and pulsatile thyrotropin secretion in normal man and woman. J Clin Endocrinol Metab. 1990;70(2):403-9. doi: 10.1210/jcem-70-2-403, PMID: 2105332.
  38. Green ME, Bernet V, Cheung J. Thyroid Dysfunction and Sleep Disorders. Front Endocrinol. 2021;12. doi: 10.3389/fendo.2021.725829, PMCID: PMC8423342, PMID: 34504473.
  39. Sridhar G, Putcha V, Lakshmi G. Sleep in thyrotoxicosis. Indian J Endocrinol Metab. 2011;15(1):23. doi: 10.4103/2230-8210.77578, PMCID: PMC3079865, PMID: 21584162.
  40. Gupta P, Jain M, Verma V, Gupta NK. The Study of Prevalence and Pattern of Thyroid Disorder in Pregnant Women: A Prospective Study. Cureus. 2021;13(7). doi: 10.7759/cureus.16457, PMCID: PMC8369967, PMID: 34422486.
  41. Kansra P, Awasthi V. Awareness of Causes, Consequences and Preventive Measures of Thyroid Disorder among Women in Punjab. Indian J Public Health Res Dev. 2020;11(6).
  42. Singh SK, Aditi A, Gupta J. Spatial clustering and meso-scale correlates of thyroid disorder among women in India: evidence from the National Family Health Survey (2015–16). J. Public Health Med. 2021:1-14. doi: 10.1007/s10389-021-01614-x.
Journal of Health Sciences & Surveillance System
Volume 12, Issue 3
July 2024
Pages 344-350
Files
Share
How to cite
Statistics